Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZI-STOP: Azithromycin in Non-CF Bronchiectasis
NCT02531984Phase 3Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Aug 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of azithromycin in Non-cystic fibrosis bronchiectasis (NCFB) (2 arms), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Time of onset of the first respiratory exacerbation at 6 months. Status: unknown.
02
Drugs
azithromycin
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT02531984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02531984.